WhatsApp Skip to main content

Dr. Harsh J Shah

Serum EV-MDM2 may be the first biomarker

GOJXf9za0AAgWju

Serum EV-MDM2 may be the first biomarker for retroperitoneal liposarcoma (RLS) recurrence. EV-MDM2 levels drop post-surgery but rise with recurrence. This can guide early detection and treatment decisions.

Dr. Harsh J Shah
Dr Harsh Shah - GI & HPB Oncosurgeon in India
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.